Lymph node dissection in small peripheral lung cancer: supplemental analysis of JCOG0802/WJOG4607L.

lymph node metastasis mediastinal lymph node dissection non-small cell lung cancer small

Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
22 Nov 2023
Historique:
received: 02 08 2023
revised: 30 10 2023
accepted: 12 11 2023
medline: 25 11 2023
pubmed: 25 11 2023
entrez: 24 11 2023
Statut: aheadofprint

Résumé

The optimal region of lymph node dissection (LND) during segmentectomy in patients with small peripheral non-small cell lung cancer requires clarification. Through a supplemental analysis of the JCOG0802/WJOG4607L, we investigated the associated factors, distribution, and recurrence pattern of lymph node metastases (LNM) and proposed the optimal LND region. Of the 1106 patients included in the JCOG0802/WJOG4607L, 1056 patients with LNDs were included in this supplemental analysis. We investigated the distribution and recurrence pattern of LNMs along with the radiological findings (with ground glass opacity [GGO], part-solid tumor; without GGO component, pure-solid tumor). The radiological findings were the only significant factor for LNMs. Of 533 patients with part-solid tumors, eight (1.5%) had LNMs. Further, only three (0.5%) patients had pN2 disease, and no patients had interlobar LNMs from non-adjacent segments. Of the 523 patients with pure-solid tumors, 55 (10.5%) had LNMs, and 28 (5.4%) had pN2 disease. Five patients had metastases to non-adjacent interlobar lymph nodes (LNs). Two (2.0%) patients with S6 tumors had upper mediastinal LNMs. In addition, the incidence of mediastinal LN recurrence in patients with S6 lung cancer was greater in those who underwent selective LND than those who underwent systematic LND (p = 0.0455). Non-adjacent interlobar and mediastinal LND have little impact on pathological nodal staging in patients with part-solid tumors. In contrast, selective LND is recommended at least for patients with pure-solid tumors.

Identifiants

pubmed: 38000629
pii: S0022-5223(23)01099-1
doi: 10.1016/j.jtcvs.2023.11.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Tomohiro Maniwa (T)

Department of Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan.

Jiro Okami (J)

Department of Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan. Electronic address: jiro.okami@oici.jp.

Tomohiro Miyoshi (T)

Division of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.

Masashi Wakabayashi (M)

JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.

Hiroshige Yoshioka (H)

Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan.

Takahiro Mimae (T)

Department of Surgical Oncology, Hiroshima University Hospital, Hiroshima, Japan.

Makoto Endo (M)

Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan.

Aritoshi Hattori (A)

Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Kazuo Nakagawa (K)

Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.

Tetsuya Isaka (T)

Department of Thoracic Surgery, Kanagawa Cancer Center, Kanagawa, Japan.

Mitsuhiro Isaka (M)

Department of Thoracic Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Ryosuke Kita (R)

JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.

Yuta Sekino (Y)

JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.

Noriko Mitome (N)

JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.

Keiju Aokage (K)

Division of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.

Hisashi Saji (H)

Department of Chest Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.

Ryu Nakajima (R)

Department of General Thoracic Surgery, Osaka City General Hospital, Osaka, Japan.

Morihito Okada (M)

Department of Surgical Oncology, Hiroshima University Hospital, Hiroshima, Japan.

Masahiro Tsuboi (M)

Division of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.

Hisao Asamura (H)

Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan.

Haruhiko Fukuda (H)

JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.

Shun-Ichi Watanabe (SI)

Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
Department of Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan.
Department of Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan.

Classifications MeSH